(NOBL) ProShares SP500 Dividend - Ratings and Ratios
Dividend Stocks, Large Cap
Dividends
| Dividend Yield | 2.05% |
| Yield on Cost 5y | 2.99% |
| Yield CAGR 5y | 4.62% |
| Payout Consistency | 94.3% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 10.6% |
| Value at Risk 5%th | 17.7% |
| Relative Tail Risk | 1.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.19 |
| Alpha | -10.68 |
| CAGR/Max DD | 0.43 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.305 |
| Beta | 0.562 |
| Beta Downside | 0.547 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.36% |
| Mean DD | 3.63% |
| Median DD | 3.17% |
Description: NOBL ProShares SP500 Dividend October 30, 2025
The ProShares S&P 500 Dividend Aristocrats ETF (ticker NOBL) seeks to replicate the performance of an index that tracks S&P 500 companies that have raised their dividends for at least 25 consecutive years. The fund invests at least 80 % of its assets in the index constituents or securities with comparable economic characteristics, aiming to deliver exposure to large-cap, high-quality dividend growers.
Key data points to note (as of the most recent filing): the fund’s expense ratio is 0.35 %, its trailing 12-month dividend yield hovers around 2.0 %, and the top ten holdings-dominated by consumer staples, industrials and health-care firms such as Procter & Gamble, Johnson & Johnson, and 3M-account for roughly 30 % of assets. Because dividend-growth stocks tend to be less cyclical, the ETF’s performance is relatively insulated from short-term interest-rate spikes, but it remains sensitive to broader equity market trends and corporate earnings health.
If you want a deeper, data-driven look at how NOBL’s valuation metrics and risk profile compare to peers, ValueRay’s analytics platform offers a free, interactive dashboard that can help you assess whether this dividend-focused strategy aligns with your investment objectives.
What is the price of NOBL shares?
Over the past week, the price has changed by -0.44%, over one month by +3.31%, over three months by +0.59% and over the past year by +0.18%.
Is NOBL a buy, sell or hold?
What are the forecasts/targets for the NOBL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 111.7 | 6.7% |
NOBL Fundamental Data Overview November 24, 2025
Beta = 0.86
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 10.99b USD (10.99b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 10.99b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 10.99b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.09% (E(10.99b)/V(10.99b) * Re(8.09%) + (debt-free company))
Discount Rate = 8.09% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for NOBL ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle